Lutein and Zeaxanthin Supplements Can Save the U.S. at Least $7 Billion in Eye-Disease Healthcare Costs
For just pennies a day, lutein and zeaxanthin supplements can save the U.S. economy significantly in age-related eye disease healthcare costs.
Lutein and zeaxanthin are key eye-health carotenoids that help maintain a healthy macular pigment by absorbing harmful blue light and protecting the eye against oxidative stress. A new economic report shows that taking specific dietary supplements can provide significant individual and societal healthcare savings by reducing the number of hospitalizations and other costly medical events associated with chronic diseases. This infographic demonstrates the cost savings that can be realized through the utilization of lutein and zeaxanthin dietary supplements among all U.S. adults over the age of 55 with age-related eye disease (ARED).
Click image above to view larger (or download original)
Courtesy of the Council for Responsible Nutrition Foundation (CRNF; Washington, DC), sourced from Frost & Sullivan’s 2013 report “Smart Prevention-Health Care Cost Savings Resulting from the Targeted Use of Dietary Supplements.”
For more infographics, visit www.supplementforsmartprevention.org
Nutritional Outlook Eye-Health Coverage
What dosage of lutein and zeaxanthin should supplement users take for optimal protection? The National Institutes of Health's five-year AREDS2 study, a follow-up to the original Age-Related Eye Disease Study (AREDS), published last year, saw benefits with a 10 mg lutein and 2 mg zeaxanthin dose. Read more about the AREDS2 findings here.
Interested in learning more about zeaxanthin? Read our latest story here.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.
